Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
FDA
Mar 27, 2024, 23:42 |
Blog
Speakers for the next open ALADDIN webinar are confirmed! - ALADDIN Education
ALADDIN Education posted on LinkedIn: “Speakers for the next open ALADDIN webinar are confirmed! Dominik Karres…
Mar 25, 2024, 15:56 |
Blog
Vivek Subbiah: Such a delight to host a JAMA Oncology podcast interview with Tobias Janowitz and Karen Winkfield
Vivek Subbiah recently posted on X: “Such a delight to host a JAMA Oncology podcast…
Mar 25, 2024, 15:43 |
Opinion
Tatiana Prowell: I have declined all 4 major media requests in the 2h since Kate Middleton announced her cancer diagnosis
Tatiana Prowell shared a post on X: “I’ve received 4 major media requests in the…
Mar 25, 2024, 06:01 |
Insight
Vivek Subbiah: For patients with NSCLC, initial use of SGT increases subsequent CGP test cancellations
Vivek Subbiah recently posted on X: "Just published in time for the ELCC24: The Impact of…
Mar 24, 2024, 00:09 |
Blog
Vivek Subbiah: Tune in to the podcast for insights into equitable access to cancer clinical trials
Vivek Subbiah posted on LinkedIn “Excited to announce my latest venture! Hosting an interview with…
Mar 22, 2024, 05:19 |
Blog
Erika Hamilton: 100 cycles on a phase I clinical trial for metastatic disease - THIS is why we do clinical trials
Erika Hamilton and Vivek Subbiah shared a post by Sarah Cannon Research Institute: "Several years ago,…
Mar 20, 2024, 16:53 |
Insight
Vincent Rajkumar: ODAC votes 11-0 to recommend approval of Cilta-Cel in patients with relapsed/refractory multiple myeloma in earlier stages
Vincent Rajkumar, Editor in Chief of Blood Cancer Journal, shared on X/Twitter: "Breaking: ODAC votes…
Mar 20, 2024, 14:37 |
Blog
Max Bronstein: The path to progress in public policy is often long, winding, and at times, completely unpredictable
Max Bronstein, Executive Director of Government Affairs and Patient Advocacy at Crinetics Pharmaceuticals, recently shared…
Mar 19, 2024, 03:22 |
Blog
Vivek Subbiah: Exceptional Responses to Selpercatinib in RET Fusion–Driven Metastatic Pancreatic Cancer
Vivek Subbiah shared a post on X/Twitter: ''Exceptional Responses to Selpercatinib in RET Fusion–Driven Metastatic…
Mar 18, 2024, 15:28 |
Blog
Vivek Subbiah: Universal germline, in addition to tumor somatic, genomic testing is needed to win the war against cancer
Vivek Subbiah recently shared a post on X/Twitter: “Pleased to share Universal Germline and Tumor…
75
76
77
78
79
All:
951
Posts:
761 - 770
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube